InvestorsHub Logo
Followers 120
Posts 20316
Boards Moderated 0
Alias Born 06/13/2011

Re: rosemountbomber post# 17331

Friday, 02/16/2024 6:52:25 PM

Friday, February 16, 2024 6:52:25 PM

Post# of 17421
I think Leerink published a note along the lines of Z's opinion .
There are however several biotech Co's interested in LN ...


” Brad H. Rovin, MD, co-chair of the guideline review, said in a press release. “With ongoing trials evaluating additional novel therapeutics and promising new data on the horizon, the guideline sets the stage for future advancements in the management and treatment of LN.”



Good luck
Kiwi
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AUPH News